| CANDRIAM EQUITIES L BIOTECHNOLOGY I-H CAP EUR | RVI BIOTECNOLOGÍA | 56,73% | 83,91% | 59,71% | 161,72% |
| FAST-EMERGING MARKETS FUND A-PF-ACC-EUR H | RVI EMERGENTES | 63,63% | 156,13% | 78,16% | 161,70% |
| BGF GLOBAL LONG-HORIZON EQUITY D4 GBP | RVI GLOBAL | 5,79% | 25,06% | 20,37% | 161,69% |
| BGF CONTINENTAL EUROPEAN FLEXIBLE A4 EUR | RVI EUROPA EX-UK | 14,34% | 36,62% | 19,48% | 161,68% |
| WAVERTON GLOBAL EQUITY FUND A USD DIS | RVI GLOBAL | 14,32% | 51,93% | 63,29% | 161,63% |
| SCHRODER ISF FRONTIER MARKETS EQUITY B ACC USD | RVI EMERGENTES | 21,19% | 69,53% | 99,36% | 161,49% |
| MFS MERIDIAN EUROPEAN RESEARCH FUND IH1-USD | RVI EUROPA | 19,62% | 38,74% | 53,17% | 161,47% |
| JPM JAPAN STRATEGIC VALUE D (ACC) JPY | RVI JAPÓN VALOR | 31,54% | 83,68% | 92,25% | 161,45% |
| SPDR S&P U.S. HEALTH CARE SELECT SECTOR UCITS ETF ACC | RVI SALUD | 26,45% | 24,30% | 37,52% | 161,45% |
| UBS (LUX) SECURITY EQUITY (CHF HEDGED) P-ACC | RVI OTROS SECTORES | 8,06% | 39,88% | 27,85% | 161,45% |
| POLAR CAPITAL NORTH AMERICAN I EUR DIS HEDGED | RVI USA | 15,77% | 61,67% | 42,71% | 161,44% |
| JPM JAPAN STRATEGIC VALUE D (ACC) EUR | RVI JAPÓN VALOR | 31,58% | 83,76% | 92,16% | 161,43% |
| JUPITER ASIA PACIFIC INCOME FUND (IRL) L USD CAP | RVI ASIA EX-JAPÓN | 48,23% | 97,01% | 77,40% | 161,43% |
| WAVERTON GLOBAL EQUITY FUND A GBP DIS | RVI GLOBAL | 14,42% | 51,88% | 63,11% | 161,42% |
| NEUBERGER BERMAN US MULTI CAP OPPORTUNITIES EUR I ACC (HEDGED) | RVI USA | 10,07% | 51,02% | 35,35% | 161,40% |
| AB SICAV I-LOW VOLATILITY EQUITY PORTFOLIO I USD | RENT. ABSOLUTA. VOLAT. BAJA | 9,63% | 41,40% | 55,20% | 161,39% |
| INVESCO HEALTH CARE S&P US SELECT SECTOR UCITS ETF ACC | RVI SALUD | 26,51% | 24,34% | 37,52% | 161,38% |
| UBS (LUX) EQUITY FUND - MID CAPS USA (USD) (CHF HEDGED) P-ACC | RVI USA SMALL/MID CAP | 3,52% | 31,74% | 12,17% | 161,37% |
| BNP PARIBAS GLOBAL MEGATRENDS I CAP | RVI GLOBAL | 15,37% | 57,94% | 48,35% | 161,32% |
| JPM GREATER CHINA C (ACC) EUR | RVI CHINA | 27,24% | 60,38% | 10,60% | 161,30% |
